MM&M News Brief - Dec. 27, 2007 - Medical Marketing and Media

Seasons Greetings!

Please enjoy this special holiday edition of News Brief featuring MM&M magazine coverage examining the year ahead. We wish our readers all the best for 2008!

Features

Outlook 2008: Electile Dysfunction

Matthew Arnold December 01, 2007

It's election season once again, and everybody's running against Big Pharma. But the industry has bigger problems.

Outlook 2008: Rubin's Rubric

Warren Ross December 01, 2007

Few analysts have proved as prescient over the years as Morgan Stanley's Jami Rubin, recently ranked third among industry analysts by Institutional Investor.

Pipeline 2008

December 01, 2007

MM&M takes a detailed look at 258 products in the pipeline, highlighting 17 of them with insights and ratings from top analysts, to provide an overall picture of each therapeutic's potential value

In Other News

UMass policy affects flow of education grants, samples

Marc Iskowitz December 27, 2007

UMass Memorial Medical Center has taken one of the most comprehensive approaches yet by a teaching hospital to limit clinician-industry interaction.

Wyeth sees generic threats, another delay on Viviant

Marc Iskowitz December 26, 2007

Competitors have stepped up efforts to market generic versions of some of Wyeth's biggest drugs, threatening to sap hundreds of millions of dollars in sales.

Federal judge rejects Maine Rx data law

Marc Iskowitz December 26, 2007

A Maine law that would have limited access by medical data companies to doctors' prescription information was reversed on constitutional grounds.

Plaintiff's Lipitor off-label case hinges on proving false claims

Marc Iskowitz December 21, 2007

The lawyer for an ex-Pfizer employee bringing a whistleblower suit against Pfizer said he isn't phased by the government's decision to refrain from the case.

GSK to shift consumer media business by end of Feb.

Marc Iskowitz December 21, 2007

GlaxoSmithKline should be finished transitioning the media planning and buying for its North American OTC business by the end of February, a spokesperson for the drugmaker said.

Product News

December 27, 2007

Merck's overseas affiliate MSD said that Isentress (raltegravir) has been granted a license from the European Union Commission.

People News

December 27, 2007

MediGene AG has appointed Frank Mathias to the executive board in charge of the new marketing division and for business development.

Webcast

5 BIG REASONS for taking pharmaceutical marketing online

Available on demand
Many pharmaceutical marketers are still unsure about entering the digital landscape and even less certain of what to do when they get there. Interactive marketing experts from Google and pharmaceutical companies discuss why marketers should take the plunge and how it could positively impact their businesses. Click here for more information and to register for this webcast.